Prospects Oncology Fund
FACIT’s Prospects Fund is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions and start-ups that fit with FACIT’s Ontario First investment strategy and have the potential to act as deal flow for the Compass Rose Fund. Prospects funding typically ranges between $50,000 and $200,000.
Prospects Fund Profile:
|Typical Funding per Project||$50k to $200k, one-time payment|
|Project Duration||Up to one year|
|Eligibility||Ontario-based academic researchers and start-ups in the oncology space|
|Type of Investment*||Grant-like with certain rights for FACIT|
|Qualifying Investment Profile||Innovative technology not incremental advance; A clear path forward for commercialization; A discrete project with quantifiable outcomes tied to funding; Oncology-related and located in Ontario; Has Ontario IP or is likely to create it|
|Main Goal of Investment||Funds should enable development and/or market research to advance the technology and support or ascertain proof-of-concept|
How to apply:
The Prospects Fund has two independent application rounds per year, with pre-submission forms accepted by:
- March 31
- September 30
Late applications will not be considered. Selected applicants will then be invited to prepare a Prospects funding package which is subject to due diligence by FACIT and final approval by FACIT’s Board of Directors.
Projects Recently Funded By The Prospects Oncology Fund
We stand behind these promising made-in-Ontario innovations.